![PDF) Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South PDF) Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South](https://www.researchgate.net/publication/356864232/figure/tbl1/AS:1098794368282638@1638984400848/Baseline-characteristics-of-the-propensity-score-matched-study-population_Q320.jpg)
PDF) Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South
![Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter](https://journals.sagepub.com/cms/10.1177/0194599820965233/asset/images/large/10.1177_0194599820965233-fig2.jpeg)
Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter
![Application of Melt Granulation Technology Using Twin-screw Extruder in Development of High-dose Modified-Release Tablet Formulation - Journal of Pharmaceutical Sciences Application of Melt Granulation Technology Using Twin-screw Extruder in Development of High-dose Modified-Release Tablet Formulation - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/attachment/2046471739/2057555417/gr1.jpg)
Application of Melt Granulation Technology Using Twin-screw Extruder in Development of High-dose Modified-Release Tablet Formulation - Journal of Pharmaceutical Sciences
![Does inhaled steroid therapy help emerging asthma in early childhood? - The Lancet Respiratory Medicine Does inhaled steroid therapy help emerging asthma in early childhood? - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/6e78f60d-726d-4c58-b64a-cac93e9104ef/gr1.jpg)
Does inhaled steroid therapy help emerging asthma in early childhood? - The Lancet Respiratory Medicine
![Improving primary care management of asthma: do we know what really works? | npj Primary Care Respiratory Medicine Improving primary care management of asthma: do we know what really works? | npj Primary Care Respiratory Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41533-020-0184-0/MediaObjects/41533_2020_184_Fig1_HTML.png)
Improving primary care management of asthma: do we know what really works? | npj Primary Care Respiratory Medicine
![Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life - CHEST Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life - CHEST](https://journal.chestnet.org/cms/asset/47aff2c7-bbaf-4c2b-9369-6456d9b4ca0e/gr1.jpg)
Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life - CHEST
![Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial - The Lancet Respiratory Medicine Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/f973cda3-f7d3-430b-8181-f0736daea0a8/gr1_lrg.jpg)
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial - The Lancet Respiratory Medicine
![JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in](https://www.mdpi.com/jpm/jpm-11-01325/article_deploy/html/images/jpm-11-01325-g001.png)
JPM | Free Full-Text | Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in
![Nocturnal eczema: Review of sleep and circadian rhythms in children with atopic dermatitis and future research directions - ScienceDirect Nocturnal eczema: Review of sleep and circadian rhythms in children with atopic dermatitis and future research directions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S009167491501252X-gr1.jpg)
Nocturnal eczema: Review of sleep and circadian rhythms in children with atopic dermatitis and future research directions - ScienceDirect
![Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter](https://journals.sagepub.com/cms/10.1177/0194599820965233/asset/images/large/10.1177_0194599820965233-fig1.jpeg)
Targeted Molecular Therapies in Allergy and Rhinology - Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter
![Ocular Pigment Dispersion with or Without Glaucoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials Ocular Pigment Dispersion with or Without Glaucoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials](https://malacards.blob.core.windows.net/network-images-v5-14-2/ocular_pigment_dispersion_with_or_without_glaucoma_related_diseases.jpg)
Ocular Pigment Dispersion with or Without Glaucoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
![Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine](https://www.jabfm.org/content/jabfp/33/2/289/F3.large.jpg)
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine
![Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions - Annals of Allergy, Asthma & Immunology Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions - Annals of Allergy, Asthma & Immunology](https://www.annallergy.org/cms/asset/e422417c-97ba-44fb-a75a-d6176ccef651/gr1.jpg)
Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions - Annals of Allergy, Asthma & Immunology
![The GINA asthma strategy report: what's new for primary care? | npj Primary Care Respiratory Medicine The GINA asthma strategy report: what's new for primary care? | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpjpcrm.2015.50/MediaObjects/41533_2015_Article_BFnpjpcrm201550_Fig1_HTML.jpg)
The GINA asthma strategy report: what's new for primary care? | npj Primary Care Respiratory Medicine
![Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine](https://www.jabfm.org/content/jabfp/33/2/289/F2.large.jpg?width=800&height=600&carousel=1)
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine
![Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine](https://www.jabfm.org/content/jabfp/33/2/289/F1.large.jpg)